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Ginkgo biloba extract was evaluated for prophylactic value 
against renal ischemia-reperfusion induced oxidant stress in rat subjected 
to transient unilateral renal artery ligation. Oral Ginkgo biloba treatment 
(2mg/kg) was administered by different schedule before experimental 
induction of ischemia-reperfusion injury. Malondialdehyde has been taken 
as indicator for free radical damage produced by ischemia-reperfusion 
injury. Three hour pretreatment by the drug has most prominent inhibitory 
effect on consequent tissue and plasma malondialdehyde level of lipid 
peroxidation. Further, the relative inhibition of malondialdehyde level in 
tissue and plasma allow to infer drug effect on generation, but not the 
clearance of malondialdehyde. No significant difference of outcome from 
1, 2 and 3 days treatment indicate no cumulation and thus safety in that 
respect. Ginkgo biloba treatment appears both effective and safe for 




Ischemia reperfusion injury is the major reason for organ dysfunction or even non function following 
transplantation, mainly of marginal organs. Ischemia-reperfusion injury also restricts the long-term survival of 
transplanted organs. Ischemia-reperfusion injury affects O2-dependent cells of tissues and organs, such as heart, 
brain, liver, kidney, and intestine. Renal ischemia–reperfusion injury is a major cause of acute renal failure and 
kidney allograft dysfunction[1]. Ischemia-reperfusion injury is a multifaceted phenomenon linking not only 
intracellular injury processes but also an injurious inflammatory response. Both the intracellular injury processes 
and the injurious events of the inflammatory response are interrelated[2]. Ischemia is a state of tissue oxygen 
deprivation accompanied by a reduced washout of the resulting metabolites[3]. Hypoxic cell injury predominates in 
the ischemic phase. Anoxic injury starts with a decrease in mitochondrial energy production.   
 
Reperfusion is the restoration of blood flow to the ischemic tissue. Upon resupply of blood, the 
inflammatory response is initiated. In this inflammatory response, macrophages, endothelial cells, neutrophils, 
lymphocytes, platelets, parenchymal cells, as well as noncellular elements, including the complement system, the 
blood coagulation cascade, reactive oxygen species, nitric oxide, and pro- and anti-inflammatory cytokines in 
addition to other mediators may be involved and the microvascular perfusion might be impaired[2]. Despite the 
unequivocal benefit of reperfusion of blood to an ischemic tissue, reperfusion itself can elicit a cascade of adverse 
reactions that paradoxically injure tissue[4]. Indeed, reperfusion injury has been well described in the literature to 
cause organ damage in the brain, heart, lungs, liver, kidneys and skeletal muscle. The susceptibility of tissue to 
ischemia reperfusion injury (IRI) is a major obstacle to both reperfusions after an infarct and successful organ 
transplantation. 
 
Molecular oxygen can be reduced by one, two or four electron transfer to produce superoxide anion (O2–), 
peroxide anion (HO2–) and finally to hydroxyl ion (HO–) respectively in biological system. Suboptimal antioxidant 
defense system leads to oxidative stress. The main component of oxidative stress are singlet oxygen (1O2), 
superoxide (O2-), hydroperoxyl (O2H.), Hydrogen peroxide (H2O2), hydroxyl radical (OH.), hypochlorus acid (HOCL) and 
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trioxocarbonate radical (CO3.-). Increased activity of nitroxidant and suboptimal anti nitroxidant defence system 
leads to nitroxidative stress. Main component of nitroxidative stress is peroxinitrite anion (ONOO-), peroxynitrous 
acid (ONOOH-), nitronium ion (NO2+), nitrogen dioxide radical (NO2.), nitryl chloride (NO2Cl) and nitrite ion (NO2-). NO 
and peroxynitrite (ONOO–) are major reactive nitrogen species in biological systems[5].  
 
Reactive oxygen species (ROS) are involved in many cellular metabolic and signaling processes and 
thought to have a role in aging[6]. ROS easily react with most biological macromolecules causing their degradation 
and destruction. ROS can cause cellular injury through their actions on phospholipids, proteins, and nucleic acids. 
High oxidative stress leads to depletion of enzymatic and nonenzymatic antioxidants[7]. The unsaturated lipid 
molecules of cell membranes are particularly susceptible to this damaging free radicals process and readily 
contribute to the uncontrolled chain reaction.  
 
Therefore, their detoxification and elimination are necessary for normal physiologic cellular activity and 
survival. Critical sites of ROS attack are the membranes of intracellular organelles, e.g. the phospholipid-rich 
lysosomal membranes. Lipid peroxidation involves the process of oxidative destruction of lipids, localized mainly in 
the cell membranes. Lipid peroxidation, well correlated with oxidative stress intensity, is a chain reaction, in which 
polyunsaturated fatty acids are degraded to small, more reactive particles such as conjugated dienes, lipid 
hydroperoxides, and thiobarbituric acid-reactive substances (TBARs)[8]. Living organisms have developed complex 
antioxidant systems to counteract reactive oxygen species and to reduce organ damage. These antioxidant systems 
include enzymes such as superoxide dismutase, catalase, and glutathione peroxidase; macromolecules such as 
albumin, ceruloplasmin, and ferritin; and a variety of small molecules, including ascorbic acid, α-tocopherol, β-
carotene, ubiquinol-10, reduced glutathione, methionine, uric acid and bilirubin[9].  
 
The aim of the present study was to determine the role of Ginkgo biloba in the treatment of rat model of 
Ischemia reperfusion injury, an oxidant-mediated disorder. Plant extracts may be an alternative to currently used 
antioxidant for controlling disease caused by excessive oxidative stress, because they constitute a rich source of 
bioactive chemicals. The most important of these bioactive constituents of plants are phenols, alkaloids, tannins, 
glycosides, flavonoids and essential oils. They could lead to the development of new classes of possibly safer 
disease control agents. Ginkgo biloba comes from the family of one of the oldest living plant species dating back 
more than 200 million years. They were the first plant to regrow after the nuclear bomb detonated in Hiroshima and 
were free of sign of genetic mutation. The effect of Ginkgo biloba may be caused by single active ingredient or by 
the combined action of many active agent found in the extract. The most important substances are flavenoids 
(flavones glycoside) and terpenoids (ginkagolides and bilobalide). The most important flavenoids are glycosides of 
camferol, quercetin and isorhamnetin with glucose rhamnose. Perfusion with the Ginkagobiloba had beneficial 
effect on ischemic / reperfused rat and Guinea pig heart in vitro and on ischemic rats heart in vivo[10]. 
 
Ginkgo biloba extract has got established for therapy of microcirculatory dysfunction and thrombotic risk. It 
is shown to antagonize platelate activating factor[11]. Antioxidant effect of Ginkgo biloba extract has been shown as 
additional beneficial property[12]. The latter would be particularly relevant to mitigate free radical damage ensuing 
with reperfusion of ischemic tissue. The damage may be ultimately indicated in terms of lipid per-oxidation in 
affected tissue and in circulation, assayable by malondialdehyde level[13]. Key consideration for any prophylactic or 
mitigating therapy of such condition with Ginkgo biloba may be the time course of drug action. The issue is complex 
being determined by pathophysiological event and kinetic and/or dynamic drug behavior. Present report attempt to 
examine the same, employing different regimens of Ginkgo biloba pretreatment in rats subjected to experimental 
renal ischemia-reperfusion injury by transient unilateral renal artery occlusion. 
 
MATERIALS AND METHODS 
 
Inbred Charles Foster (CF) strain albino rat weighing 200-250g of either sex, obtained from the Central 
animal house of Institute of Medical Sciences, Banaras Hindu University, Varanasi were kept in departmental 
animal house at 260±20C, 44-56% relative humidity and 10:14 hr L:D cycle for one week before and during the 
experiments. Animals were provided with standard rodent pellet diet and water was given ad libitum. Principles of 
laboratory animal care (NIH publication no. 82-23 revised 1985) guidelines were followed. Approval from the 
Institutional Animal Ethical committee was taken prior to the experimental work. Experimental group composed of 
six animals in each. 
 
Animal fasted overnight were anaesthetized with pentobarbitone (40 mg/kg, i.p.) through lateral flank 
incision, left kidney was accessed. The left renal artery was occluded with non traumatic vascular clamp for 1 hour 
period. Consequently the clamp was released and allowing 5 minute period thereafter (reperfusion), blood sample 
was drawn as maximal aspiration with intracardiac syringing. The left kidney subjected to procedure was removed, 
briskly rinsed in cold (40C) normal saline and taken in previously weighed beaker with normal saline and 1 drop of 
1% beta hydroxyl toluene solution. The same was weighed again to deduce the weight of tissue. 
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Control group of animals were shame operated without renal artery maneuver. After uneventful 1 hour post 
surgical period sample of blood and left kidney were similarly harvested. All the animals were then scarified by 
cervical dislocation. 
 
Ginkgo biloba treatment 
 
Ginkgo biloba extract (Ginkoba-Microlab) (2 mg/100gm) was administered orally in aqueous 1 % gum 
acacia suspension. Pretreatment schedule followed as under: Single dose, at one hour before renal artery ligation, 
three hour before renal artery ligation and day before renal artery ligation. Multiple dose- Twice daily dose on 
preceding 2 days and thrice daily dose on preceding 2 days. 
 
Malondialdehyde estimation [14] 
 
Plasma malondialdehyde: The reaction mixture contained 0.4 ml of plasma, 0.2 ml of sodium dodecyl 
sulfate, 1.5 ml of 20% acetic acid and 1.5 ml of 0.8% aqueous solution of thiobarbituric acid. The mixture was 
finally made to 4 ml with distilled water and heated at 950C for 60 min. After cooling with tap water, 1 ml of distilled 
water and 5 ml of mixture of n-butanol and pyridine were added, and the mixture was shaken vigorously after 
centrifugation at 4000 rpm for 10 min., the absorbance of the organic layer was measured at 532 nm with 
Spectrophotometer (Systronic). Malondialdehyde (in nM) estimation was done from the standard curve prepared 
with 1,1,3,3-tetra methoxy propane. 
 
Tissue malondialdehyde: The reaction mixture contained 0.4 ml of tissue homogenate, 0.2 ml of sodium 
dodecyl sulfate, 1.5 ml of 20% acetic acid and 1.5 ml of 0.8% aqueous solution of thiobarbituric acid. The mixture 
was finally made to 4 ml with distilled water and heated at 950C for 60 min. After cooling with tap water, 1 ml of 
distilled water and 5 ml of mixture of n-butanol and pyridine were added, and the mixture was shaken vigorously 
after centrifugation at 4000 rpm for 10 min., the absorbance of the organic layer was measured at 532 nm with 
Spectrophotometer (Systronic). Malondialdehyde (in nM) estimation was done from the standard curve prepared 








Plasma and tissue malondialdehyde profile expressed as nanomoles per liter using 1,1,3,3-tetra methoxy 
propane standard curves are displayed in table 1 and figure 1. On the basis of above experiment (effect of Ginkgo 
biloba treatment for different time schedule on experimentally induced renal ischemia-reperfusion injury in albino 
rat) following results may be drawn. 
 
Ginkgo biloba was given 1 hour before induction of renal ischemia-reperfusion injury reduced 
malondialdehyde level 65% in blood 25% in tissue. Administration of same dose 3 hour before induction of renal 
ischemia-reperfusion injury decreased malondialdehyde level by 95% in blood and 56% in tissue. However, Ginkgo 
biloba given 1 day before also reduces blood and tissue Malondialdehyde level about 57% and 35% respectively. 
 
Ginkgo biloba was given for 2 days (Twice daily) and 3 days (thrice daily) does not show any superiority 
over Ginkgo biloba given one day before induction of renal ischemia-reperfusion injury. 
 
Table 1. Comparative profile of plasma and tissue malondialdehyde in rats treated with Ginkgo biloba for different 
time duration prior to ischemia reperfusion injury and in rats without Ginkgo biloba (n=6 in each group) 
 
S.No. Drug Schedules Treatment Malondialdehyde in nanomoles per litre (Mean±SEM) 
Blood Kidney tissue 
1. Sham 3.91 ±0.23 2.3±0.28 
2. Isc / rep 11.8±1.13 6.4±0.52 
3. 1 hr before 4.08±0.08** 4.0±0.1** 
4. 3 hr before 1.0±0.1** 2.8±0.1** 
5. For 1 day (o.d.) 5.0±0.08** 4.16±0.1** 
6. For 2 day (b.d.) 5.33±0.3** 4.15±0.38** 
7. For 3 day (t.d.s.) 4.58±0.69** 4.33±0.2** 
 





RRJPTS | Volume 2 | Issue 1 | January - March, 2014                  50 
 
 
Figure 1. Comparative profile (Percentage) of plasma and tissue malondialdehyde in rats treated with Ginko biloba 
for different time duration prior to ischemia reperfusion injury and in rats without Ginko biloba (n=6 in each group) 




 Anoxic injury starts with a decrease in mitochondrial energy production.  The cytosolic pH decreases 
directly owing to ATP degradation, to increased glycolytic rate, and possibly to liberation of H+ from damaged 
lysosomes. The cytosolic pH decreases directly owing to ATP degradation, to increased glycolytic rate, and possibly 
to liberation of H+ from damaged lysosomes. Almost in parallel, cellular ion homeostasis becomes impaired, 
eventually resulting in increased cytosolic Na+ and Ca2+concentrations. An increase in cytosolic Ca2+ concentration 
may activate hydrolases, such as phospholipases (especially phospholipase A2) and proteases (calpains and 
others). The hydrolases may further enhance the injury process by degradation of their substrates (eg, by calpain-
mediated proteolysis of cytoskeletal proteins). Increased cellular sodium may cause osmotic swelling, which may 
contribute to disruption of the plasma membrane (2). Upon resupply of blood, the inflammatory response is 
initiated. In the ischemic phase electron-transferring enzymes, such as those of the mitochondrial respiratory chain, 
may be damaged. Upon reperfusion of the still viable cells, electrons are transferred to O2 by the damaged 
enzymes, resulting in the formation of reactive oxygen species, thus initiating a reactive oxygen speciesmediated 
injury to these cells[15].  
 
The experiment of renal artery ligation induced renal ischemia-reperfusion injury yielded significant rise in 
tissue and plasma level of lipid peroxidation marker malondialdehyde, validating the employed procedure. All 
regimen of Ginkgo biloba pretreatment significantly reduced such rise indicating a protective effect. Inhibition of 
lipid peroxidation was most marked at 3 hour after treatment, both in tissue and plasma. That should reflect the 
optimal course for buildup of drug concentration at site of injury. Tissue malondialdehyde levels which may indicate 
ischemia reperfusion injury induced generation of free radical stress consistently and more prominently. Plasma 
malondialdehyde level may be taken to be result of malondialdehyde shed by injured tissue. Ginkgo biloba effects 
were more prominent on plasma malondialdehyde levels. 
 
No significant difference in inhibitory profile of Ginkgo biloba given by serial more intensive schedule of 1, 
2 and 3 days reveals lack of cumulative profile of studied schedule. Clinical inference of the finding is that Ginkgo 
biloba treatment has protective value in mitigating reperfusion injury following ischemic episodes and may be safe 
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